Alector, Inc. (ALEC) vs Nautilus Biotechnolgy, Inc. (NAUT)

A side-by-side comparison of Alector, Inc. and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALEC vs NAUT

growth of $100 · dividends reinvested · last 6y
ALEC -86.6% (-28.5%/yr)NAUT -82.1% (-24.9%/yr)NAUT compounded faster over this window
0100200Start $100202120222023202420252026$13$18
ALEC NAUT

ALEC vs NAUT: by the numbers

  • •NAUT is the larger company ($244M vs $218M market cap).
  • •Both run net losses; ALEC's is the smaller (-850.13% vs -29747.89% net margin).

Metrics side by side

Valuation

MetricALECNAUT
P/S ratio15.701285.95
P/B ratioN/A1.86

Profitability

MetricALECNAUT
Gross margin54.09%0.00%
Operating margin-692.83%0.00%
Net margin-850.13%-29747.89%
ROEN/A-43.11%
ROIC-71.04%-40.52%

Growth (annualized)

MetricALECNAUT
Revenue CAGR (5Y)-8.35%N/A
Total return CAGR (5Y)-39.17%-20.56%

Frequently asked

How have ALEC and NAUT total returns compared?
Over the past 5 years, ALEC delivered -39.17% and NAUT delivered -20.56% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.